Interestingly, TSPAN30 was the only tetraspanin that was significantly associated with all six clinical characteristics: grading, IDH mutation status, 1p/19q co-deletion status, sex, age, and recurrence, suggesting that more research is needed regarding the role of TSPAN30 in GBM. The gene discussed is IDH2; the disease is glioblastoma.